News
Hosted on MSN7d
Alpha-1 antitrypsin deficiency: Study reveals why some patients with the hereditary disease remain healthyThis regulation is crucial, and an overactive immune response can cause serious lung diseases ... capturing alpha-1 ...
today unveiled a preclinical program for the treatment of alpha-1 antitrypsin deficiency (AATD), the next program within its liver franchise. Prime Medicine expects to file an investigational new ...
Korro formed a Clinical Advisory Board, consisting of esteemed lung ... College of Chest Physicians (CHEST) Journal published, “Editing Approaches to Treat Alpha-1 Antitrypsin Deficiency.” ...
Korro Bio, Inc. announced that its investigational drug KRRO-110 has received orphan drug designation from the FDA for treating Alpha-1 Antitrypsin Deficiency ... to serious lung and liver ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback